World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 12 December 2020
Main ID:  NCT02672189
Date of registration: 26/01/2016
Prospective Registration: No
Primary sponsor: The Netherlands Cancer Institute
Public title: Internet-based Cognitive Behavioral Therapy for Breast Cancer Patients With Climacteric Symptoms
Scientific title: A Randomized Controlled Trial of Internet-based Cognitive Behavioral Therapy for Breast Cancer Patients With Climacteric Symptoms
Date of first enrolment: February 2015
Target sample size: 254
Recruitment status: Completed
URL:  https://clinicaltrials.gov/show/NCT02672189
Study type:  Interventional
Study design:  Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: None (Open Label).  
Phase:  Phase 3
Countries of recruitment
Netherlands
Contacts
Name:     Hester S.A. Oldenburg, PhD
Address: 
Telephone:
Email:
Affiliation:  The Netherlands Cancer Institute
Name:     Marc Van Beurden, PhD
Address: 
Telephone:
Email:
Affiliation:  The Netherlands Cancer Institute
Name:     Neil K. Aaronson, PhD
Address: 
Telephone:
Email:
Affiliation:  The Netherlands Cancer Institute
Key inclusion & exclusion criteria

Age limit: stated age concerns age at time of diagnosis.

Inclusion Criteria:

- Female

- Diagnosis of histologically confirmed primary breast cancer

- 50 years or younger at time of diagnosis

- Premenopausal at time of diagnosis

- Treatment induced menopause due to at least one of the following treatment regimens:
1) chemotherapy (< 5 years > 4 months); 2) hormonal therapy (<5 years; may currently
receive hormonal treatment); oophorectomy (< 5 years > 4 months)

- Disease free at time of study entry

- Presence of menopausal symptoms

Exclusion Criteria:

- Lacks basic proficiency in Dutch

- No access to the internet

- Serious cognitive or psychiatric problems

- Participation in concurrent studies and/or therapy programs to alleviate menopausal
symptoms



Age minimum: 18 Years
Age maximum: 55 Years
Gender: Female
Health Condition(s) or Problem(s) studied
Breast Cancer Survivors
Climacteric Symptoms
Intervention(s)
Behavioral: EVA-Online
Primary Outcome(s)
Change in vasomotor symptoms [Time Frame: Baseline (T0); 10 weeks post baseline (T1) and 6 months post baseline (T2)]
Change in overall levels of menopausal symptoms [Time Frame: Baseline (T0); 10 weeks post baseline (T1) and 6 months post baseline (T2)]
Secondary Outcome(s)
Change in sleep quality [Time Frame: Baseline (T0); 10 weeks post baseline (T1) and 6 months post baseline (T2)]
Change in health related quality of life [Time Frame: Baseline (T0); 10 weeks post baseline (T1) and 6 months post baseline (T2)]
Change in hot flush frequency [Time Frame: Baseline (T0); 10 weeks post baseline (T1) and 6 months post baseline (T2)]
Change in overall levels of sexual functioning [Time Frame: Baseline (T0); 10 weeks post baseline (T1) and 6 months post baseline (T2)]
Change in psychological distress [Time Frame: Baseline (T0); 10 weeks post baseline (T1) and 6 months post baseline (T2)]
Secondary ID(s)
NKI 2014-6788 / NL53182.031.15
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Dutch Cancer Society
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history